Journal article
International clinical practice guidelines including guidance for direct oral anticoagulants in the treatment and prophylaxis of venous thromboembolism in patients with cancer
Abstract
Venous thromboembolism (VTE) is the second leading cause of death in patients with cancer. These patients are at an increased risk of developing VTE and are more likely to have a recurrence of VTE and bleeding while taking anticoagulants. Management of VTE in patients with cancer is a major therapeutic challenge and remains suboptimal worldwide. In 2013, the International Initiative on Thrombosis and Cancer (ITAC-CME), established to reduce the …
Authors
Farge D; Bounameaux H; Brenner B; Cajfinger F; Debourdeau P; Khorana AA; Pabinger I; Solymoss S; Douketis J; Kakkar A
Journal
The Lancet Oncology, Vol. 17, No. 10, pp. e452–e466
Publisher
Elsevier
Publication Date
10 2016
DOI
10.1016/s1470-2045(16)30369-2
ISSN
1470-2045